Meeting
2013 ASCO Annual Meeting
Identification of the activated form of the progesterone receptor (PR) in breast cancer (BC).
Authors
Jacques Bosq
Institut Gustave Roussy, Villejuif, France
Jacques Bosq , Jean-Michel Caillaud , Carol A. Lange , Suzanne A. W. Fuqua , Joyce O'Shaughnessy , Erard M. Gilles , Alexander A. Zukiwski , Jacques Bonneterre
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 31, 2013 (suppl; abstr 593)
DOI
10.1200/jco.2013.31.15_suppl.593
Abstract #
593
Poster Bd #
7H
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Determination of the activated form of the progesterone receptor (PR) in endometrial cancer (EC).
First Author: Dinny Graham
Poster
2023 ASCO Annual Meeting
Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer.
First Author: Esther G Chong
Poster
2015 ASCO Annual Meeting
Variations in measured ER, PR, and HER2 status in synchronous and asynchronous paired breast cancer (BC) tumors.
First Author: Clayton Yates
Poster
2013 ASCO Annual Meeting
Ki-67 level in hormone reptor positive breast cancer patients: A retrospective review of 9,061 Korean women.
First Author: Jisun Kim